BackOrphazyme A/S Overview

Orphazyme A/S Total Liabilities

Track Orphazyme A/S's total liabilities ($1.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$1.76M
75.87% YoYΔ $-5.54M vs prior year quarter

Peer trimmed avg / median

Loading

Orphazyme A/S Total Liabilities History

Loading

Orphazyme A/S vs. peers: Total Liabilities Comparison

Loading

Orphazyme A/S Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orphazyme A/S (ORPHY) FAQ

As of the most recent data (June 2024), ORPHY shows a total liabilities of $1.8M. That compares with $7.3M in the prior-year period — down 75.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORPHY's total liabilities is now $1.8M (was $7.3M) — a 75.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Orphazyme A/S is outperforming or lagging.

Tracking ORPHY's total liabilities over time shows whether Orphazyme A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $1.8M That compares with $7.3M in the prior-year period — down 75.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Orphazyme A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $1.8M) with ownership activity and broader fundamentals.

Orphazyme A/S's total liabilities is $1.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.